Correction: Expert Narrative Review of the Safety of Cladribine Tablets for the Management of Relapsing Multiple Sclerosis
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Adis, Springer Healthcare
2023-11-01
|
| Series: | Neurology and Therapy |
| Online Access: | https://doi.org/10.1007/s40120-023-00564-8 |
| _version_ | 1797355473779818496 |
|---|---|
| author | Pierre Clavelou Giovanni Castelnovo Valérie Pourcher Jerome De Sèze Patrick Vermersch Ali-Frederic Ben-Amor Carine Savarin Gilles Defer |
| author_facet | Pierre Clavelou Giovanni Castelnovo Valérie Pourcher Jerome De Sèze Patrick Vermersch Ali-Frederic Ben-Amor Carine Savarin Gilles Defer |
| author_sort | Pierre Clavelou |
| collection | DOAJ |
| first_indexed | 2024-03-08T14:11:41Z |
| format | Article |
| id | doaj.art-e3d9e2e289314c2f9330874b941881d8 |
| institution | Directory Open Access Journal |
| issn | 2193-8253 2193-6536 |
| language | English |
| last_indexed | 2024-03-08T14:11:41Z |
| publishDate | 2023-11-01 |
| publisher | Adis, Springer Healthcare |
| record_format | Article |
| series | Neurology and Therapy |
| spelling | doaj.art-e3d9e2e289314c2f9330874b941881d82024-01-14T12:43:07ZengAdis, Springer HealthcareNeurology and Therapy2193-82532193-65362023-11-0113125525610.1007/s40120-023-00564-8Correction: Expert Narrative Review of the Safety of Cladribine Tablets for the Management of Relapsing Multiple SclerosisPierre Clavelou0Giovanni Castelnovo1Valérie Pourcher2Jerome De Sèze3Patrick Vermersch4Ali-Frederic Ben-Amor5Carine Savarin6Gilles Defer7Department of Neurology, Clermont-Ferrand University HospitalDepartment of Neurology, Nîmes University Hospital, Hopital CaremeauDepartment of Infectious and Tropical Diseases, Pitié-Salpêtrière Hospital, APHP, Sorbonne Université, INSERM 1136, Institut Pierre Louis d’Epidémiologie et de Santé Publique ParisDepartment of Neurology, Strasbourg University HospitalUniv. Lille, Inserm U1172 LilNCog, CHU Lille, FHU PreciseGlobal Medical Affairs Neurology and Immunology, Ares Trading SA (An affiliate of Merck KGaA, Darmstadt, Germany)Neurology Department, Medical Affairs (An affiliate of Merck KGaA, Darmstadt, Germany)Department of Neurology, Caen University Hospitalhttps://doi.org/10.1007/s40120-023-00564-8 |
| spellingShingle | Pierre Clavelou Giovanni Castelnovo Valérie Pourcher Jerome De Sèze Patrick Vermersch Ali-Frederic Ben-Amor Carine Savarin Gilles Defer Correction: Expert Narrative Review of the Safety of Cladribine Tablets for the Management of Relapsing Multiple Sclerosis Neurology and Therapy |
| title | Correction: Expert Narrative Review of the Safety of Cladribine Tablets for the Management of Relapsing Multiple Sclerosis |
| title_full | Correction: Expert Narrative Review of the Safety of Cladribine Tablets for the Management of Relapsing Multiple Sclerosis |
| title_fullStr | Correction: Expert Narrative Review of the Safety of Cladribine Tablets for the Management of Relapsing Multiple Sclerosis |
| title_full_unstemmed | Correction: Expert Narrative Review of the Safety of Cladribine Tablets for the Management of Relapsing Multiple Sclerosis |
| title_short | Correction: Expert Narrative Review of the Safety of Cladribine Tablets for the Management of Relapsing Multiple Sclerosis |
| title_sort | correction expert narrative review of the safety of cladribine tablets for the management of relapsing multiple sclerosis |
| url | https://doi.org/10.1007/s40120-023-00564-8 |
| work_keys_str_mv | AT pierreclavelou correctionexpertnarrativereviewofthesafetyofcladribinetabletsforthemanagementofrelapsingmultiplesclerosis AT giovannicastelnovo correctionexpertnarrativereviewofthesafetyofcladribinetabletsforthemanagementofrelapsingmultiplesclerosis AT valeriepourcher correctionexpertnarrativereviewofthesafetyofcladribinetabletsforthemanagementofrelapsingmultiplesclerosis AT jeromedeseze correctionexpertnarrativereviewofthesafetyofcladribinetabletsforthemanagementofrelapsingmultiplesclerosis AT patrickvermersch correctionexpertnarrativereviewofthesafetyofcladribinetabletsforthemanagementofrelapsingmultiplesclerosis AT alifredericbenamor correctionexpertnarrativereviewofthesafetyofcladribinetabletsforthemanagementofrelapsingmultiplesclerosis AT carinesavarin correctionexpertnarrativereviewofthesafetyofcladribinetabletsforthemanagementofrelapsingmultiplesclerosis AT gillesdefer correctionexpertnarrativereviewofthesafetyofcladribinetabletsforthemanagementofrelapsingmultiplesclerosis |